IBDEI0XB ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16447,2)
 ;;=^336610
 ;;^UTILITY(U,$J,358.3,16448,0)
 ;;=787.21^^92^937^21
 ;;^UTILITY(U,$J,358.3,16448,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16448,1,4,0)
 ;;=4^787.21
 ;;^UTILITY(U,$J,358.3,16448,1,5,0)
 ;;=5^Dysphagia,Oral Phase
 ;;^UTILITY(U,$J,358.3,16448,2)
 ;;=^335276
 ;;^UTILITY(U,$J,358.3,16449,0)
 ;;=787.22^^92^937^22
 ;;^UTILITY(U,$J,358.3,16449,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16449,1,4,0)
 ;;=4^787.22
 ;;^UTILITY(U,$J,358.3,16449,1,5,0)
 ;;=5^Dysphagia,Oropharyngeal
 ;;^UTILITY(U,$J,358.3,16449,2)
 ;;=^335277
 ;;^UTILITY(U,$J,358.3,16450,0)
 ;;=787.23^^92^937^23
 ;;^UTILITY(U,$J,358.3,16450,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16450,1,4,0)
 ;;=4^787.23
 ;;^UTILITY(U,$J,358.3,16450,1,5,0)
 ;;=5^Dysphagia,Pharyngeal
 ;;^UTILITY(U,$J,358.3,16450,2)
 ;;=^335278
 ;;^UTILITY(U,$J,358.3,16451,0)
 ;;=787.24^^92^937^24
 ;;^UTILITY(U,$J,358.3,16451,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16451,1,4,0)
 ;;=4^787.24
 ;;^UTILITY(U,$J,358.3,16451,1,5,0)
 ;;=5^Dysphagia,Pharyngoesoph
 ;;^UTILITY(U,$J,358.3,16451,2)
 ;;=^335279
 ;;^UTILITY(U,$J,358.3,16452,0)
 ;;=787.29^^92^937^20
 ;;^UTILITY(U,$J,358.3,16452,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16452,1,4,0)
 ;;=4^787.29
 ;;^UTILITY(U,$J,358.3,16452,1,5,0)
 ;;=5^Dysphagia NEC
 ;;^UTILITY(U,$J,358.3,16452,2)
 ;;=^335280
 ;;^UTILITY(U,$J,358.3,16453,0)
 ;;=584.9^^92^938^2
 ;;^UTILITY(U,$J,358.3,16453,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16453,1,4,0)
 ;;=4^584.9
 ;;^UTILITY(U,$J,358.3,16453,1,5,0)
 ;;=5^Acute Renal Failure
 ;;^UTILITY(U,$J,358.3,16453,2)
 ;;=^67114
 ;;^UTILITY(U,$J,358.3,16454,0)
 ;;=583.9^^92^938^19
 ;;^UTILITY(U,$J,358.3,16454,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16454,1,4,0)
 ;;=4^583.9
 ;;^UTILITY(U,$J,358.3,16454,1,5,0)
 ;;=5^Glomerulonephritis
 ;;^UTILITY(U,$J,358.3,16454,2)
 ;;=^83446
 ;;^UTILITY(U,$J,358.3,16455,0)
 ;;=403.90^^92^938^51
 ;;^UTILITY(U,$J,358.3,16455,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16455,1,4,0)
 ;;=4^403.90
 ;;^UTILITY(U,$J,358.3,16455,1,5,0)
 ;;=5^Renal Insufficiency with Hypertension (CRI and HTN)
 ;;^UTILITY(U,$J,358.3,16455,2)
 ;;=Renal Insufficiency with Hypertension (CRI and HTN)^269609
 ;;^UTILITY(U,$J,358.3,16456,0)
 ;;=593.9^^92^938^9
 ;;^UTILITY(U,$J,358.3,16456,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16456,1,4,0)
 ;;=4^593.9
 ;;^UTILITY(U,$J,358.3,16456,1,5,0)
 ;;=5^Chronic Renal Insufficiency
 ;;^UTILITY(U,$J,358.3,16456,2)
 ;;=Chronic Renal Insufficiency^123849
 ;;^UTILITY(U,$J,358.3,16457,0)
 ;;=581.9^^92^938^37
 ;;^UTILITY(U,$J,358.3,16457,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16457,1,4,0)
 ;;=4^581.9
 ;;^UTILITY(U,$J,358.3,16457,1,5,0)
 ;;=5^Nephrotic Syndrome
 ;;^UTILITY(U,$J,358.3,16457,2)
 ;;=^82357
 ;;^UTILITY(U,$J,358.3,16458,0)
 ;;=753.12^^92^938^43
 ;;^UTILITY(U,$J,358.3,16458,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16458,1,4,0)
 ;;=4^753.12
 ;;^UTILITY(U,$J,358.3,16458,1,5,0)
 ;;=5^Polycystic Kidney Disease
 ;;^UTILITY(U,$J,358.3,16458,2)
 ;;=^67295
 ;;^UTILITY(U,$J,358.3,16459,0)
 ;;=791.0^^92^938^45
 ;;^UTILITY(U,$J,358.3,16459,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16459,1,4,0)
 ;;=4^791.0
 ;;^UTILITY(U,$J,358.3,16459,1,5,0)
 ;;=5^Proteinuria
 ;;^UTILITY(U,$J,358.3,16459,2)
 ;;=Proteinuria^99873
 ;;^UTILITY(U,$J,358.3,16460,0)
 ;;=791.9^^92^938^48
 ;;^UTILITY(U,$J,358.3,16460,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16460,1,4,0)
 ;;=4^791.9
 ;;^UTILITY(U,$J,358.3,16460,1,5,0)
 ;;=5^Pyuria
 ;;^UTILITY(U,$J,358.3,16460,2)
 ;;=^273408
 ;;^UTILITY(U,$J,358.3,16461,0)
 ;;=592.0^^92^938^49
